FACIT's Prospects Fund fuels women's health and brain cancer therapies for Ontario patients
/PRNewswire/ - FACIT congratulates Ontario-based start-ups Hyivy Health and HDAX Therapeutics as the latest recipients of capital through its Prospects...
Stay updated with breaking news from Triphase Accelerator. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ - FACIT congratulates Ontario-based start-ups Hyivy Health and HDAX Therapeutics as the latest recipients of capital through its Prospects...
/PRNewswire/ - FACIT, a commercialization-venture firm, announced the appointment of Dr. Kuldeep Neote, as an Executive-in-Residence (EIR) to accelerate...
Share this article Showcasing Ontario's emerging biotech entrepreneurs and driving value from intellectual property TORONTO, Feb. 4, 2021 /PRNewswire/ - FACIT, a commercialization venture firm for Ontario cancer innovations, congratulates the 2021 winner of its Falcons' Fortunes pitch competition, Waterloo-based start-up Air Microfluidic Systems Inc. The winning pitch, delivered by CEO Mr. Run Ze Gao, focused on the development of an air microfluidics-enabled active compression sleeve for treating breast cancer-related lymphedema. FACIT hosts the annual pitch competition as part of its broa...
FACIT welcomes life sciences executive Ken Newport to its Board; Director Shana Kelley appointed to the Order of Ontario News provided by Share this article Share this article Blend of scientific, industry, investment and entrepreneurial expertise complements FACIT's leading role in growing Ontario's life sciences commercialization TORONTO, Jan. 26, 2021 /PRNewswire/ - The Board of Directors of FACIT, a commercialization venture firm for Ontario cancer innovations, is pleased to report on the addition of Mr. Ken Newport, in the role of Director. Mr. Newport is a passionate executive and advo...
Ontario First capital supports early stage commercialization of cancer intellectual property TORONTO, Dec. 10, 2020 /PRNewswire/ - FACIT, Ontario's oncology commercialization venture firm, announced the newest recipients of Ontario First seed capital through the latest round of its Prospects Oncology Fund: Dr. Rebecca Laposa of the University of Toronto, as well as London-based start-up Multi-Magnetics Inc., scientifically led by Dr. Jeffrey Carson and spun out of the Lawson Health Research Institute. Both entrepreneurial scientists were previously finalists in FACIT's Falcons' Fortunes pitc...